| PUBCHEM ID |
9281
|
| UNII |
X44P41F7ZK
|
| Preferred Term |
NITROBLUE TETRAZOLIUM CHLORIDE
|
| CAS |
298-83-9
|
| INCHIKEY |
FSVCQIDHPKZJSO-UHFFFAOYSA-L
|
| Download |
mol2, pdbqt
|
| mol2 |
|
| Smiles |
COc(cc(cc1)-c(cc2)cc(OC)c2-n2nc(-c3ccccc3)nn2-c(cc2)ccc2[N@@H+]([O-])O)c1-n1nc(-c2ccccc2)nn1-c(cc1)ccc1[N@H+]([O-])O
|
| Total Surface Area |
586,32
|
| Relative PSA |
0,30499
|
| TPSA |
173,22
|
| cLogS |
-11,426
|
| MW |
750,774
|
| cLogP |
7,3052
|
| H-Acceptors |
16
|
| H-Donors |
4
|
| Ro5 violations |
3
|
| Druglikeness |
-5,4013
|
| DrugScore |
9,30646698342197E-03
|
| Mutagenic |
high
|
| Tumorigenic |
high
|
| Reproductive Effective |
high
|
| Irritant |
high
|
| Blood-Brain Barrier |
BBB+
|
| Human Intestinal Absorption |
HIA+
|
| Caco-2 Permeability I |
Caco2-
|
| Caco-2 Permeability II |
0,6366
|
| P-glycoprotein Substrate |
Non-substrate
|
| P-glycoprotein Inhibitor I |
Non-inhibitor
|
| P-glycoprotein Inhibitor II |
Non-inhibitor
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Subcellular localization |
Mitochondria
|
| CYP450 2C9 Substrate |
Non-substrate
|
| CYP450 2D6 Substrate |
Non-substrate
|
| CYP450 3A4 Substrate |
Substrate
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Inhibitor
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP Inhibitory Promiscuity |
High CYP Inhibitory Promiscuity
|
| Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition II |
Non-inhibitor
|
| AMES Toxicity |
AMES toxic
|
| Carcinogens |
Non-carcinogens
|
| Fish Toxicity I |
High FHMT
|
| Fish Toxicity II |
0,9341
|
| Tetrahymena Pyriformis Toxicity I |
High TPT
|
| Tetrahymena Pyriformis Toxicity II |
0,9507
|
| Tetrahymena Pyriformis Toxicity |
Low HBT
|
| Biodegradation |
Not ready biodegradable
|
| Acute Oral Toxicity |
III
|
| Rat Acute Toxicity |
2,2876
|
| Carcinogenicity (Three-class) |
Non-required
|